1 |
Miksicek, R.J. 1994. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J. Steroid Biochem. Mol. Biol. 49:153-160.
DOI
ScienceOn
|
2 |
Oliveira, C.A., R. Nie, K. Carnes, L.R. Franca, G.S. Prins, P.T. Saunders and R.A. Hess. 2003. The antiestrogen ICI 182,780 decreases the expression of estrogenreceptor-alpha but has no effect on estrogenreceptor-beta and androgen receptor in rat efferent ductules. Reprod. Biol. Endocrinol. 1:75.
DOI
ScienceOn
|
3 |
Park, J.H., S.M. Oh, S.S. Lim, Y.S. Lee, H.K. Shin, Y.S. Oh, N.H. Choe, J.H. Park and J.K. Kim. 2006. Induction of heme oxygenase-1 mediates the anti-inflammatory effects of the ethanol extract of Rubus coreanus in murine macrophages. Biochem. Biophys. Res. Commun. 351:146-152.
DOI
ScienceOn
|
4 |
Simonet, W.S., D.L. Lacey, C.R. Dunstan, M. Kelley, M.S. Chang, R. Luthy, H.Q. Nguyen, S. Wooden, L. Bennett, T. Boone, G. Shimamoto, M. DeRose, R. Elliott, A. Colombero, H.L. Tan, G. Trail, J. Sullivan, E. Davy, N. Bucay, L. Renshaw-Gegg, T.M. Hughes, D. Hill, W. Pattison, P. Campbell, S. Sander, G. Van, J. Tarpley, P. Derby, R. Lee and W.J. Boyle. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
DOI
ScienceOn
|
5 |
Khosla, S. 2001. Minireview: the OPG/RANKL/RANK system. Endocrinology 142:5050-5055.
DOI
|
6 |
Kostenuik, P.J. and V. Shalhoub. 2001. Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. Curr. Pharm. Des. 7:613-635.
DOI
ScienceOn
|
7 |
Koo, H.J., E.H. Sohn, Y.J. Kim, S.A. Jang, S. Namkoong and S.C. Kang. 2014a. Effect of the combinatory mixture of Rubus coreanus Miquel and Astragalus membranaceus Bunge extracts on ovariectomy-induced osteoporosis in mice and anti-RANK signaling effect. J. Ethnopharmacol. 151:951-959.
DOI
|
8 |
Koo, H.J., S.C. Kang, S.A. Jang, J.E. Kwon, E. Sohn and E.H. Sohn. 2014b. Effects of protocatechuic acid derived from Rubus coreanus on the lipid metabolism in high cholesterol diet-induced mice. Korean J. Plant Res. 27:271-278.
과학기술학회마을
DOI
|
9 |
Lee, J.E., S.M. Cho, E. Park, S.M. Lee, Y. Kim, J.H. Auh, H.K. Choi, S. Lim, S.C. Lee and J.H. Kim. 2014. Anti-inflammatory effects of Rubus coreanus Miquel through inhibition of NF- and MAP Kinase. Nutr. Res. Pract. 8:501-508.
과학기술학회마을
DOI
|
10 |
Lee, K.H. and E.M. Choi. 2006. Rubus coreanus Miq. extract promotes osteoblast differentiation and inhibits bone-resorbing mediators in MC3T3-E1 cells. Am. J. Chin. Med. 34:643-654.
DOI
ScienceOn
|
11 |
Marsden, J. 2002. The menopause, hormone replacement therapy and breast cancer. J. Steroid Biochem. Mol. Biol. 83:123-132.
DOI
|
12 |
McNamara, L.M. 2010. Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures. J. R. Soc. Interface 7:353-372.
DOI
|
13 |
Riggs, B.L., S. Khosla and L.J. Melton III. 2002. Sex steroids and the construction and conservation of the adult skeleton. Endocr. Rev. 23:279-302.
DOI
|
14 |
Kansra, S., S. Chen, M.L. Bangaru, L. Sneade, J.A. Dunckley and N. Ben-Jonathan. 2010. Selective estrogen receptor down-regulator and selective estrogen receptor modulators differentially regulate lactotroph proliferation. PLoS One 5:e10060.
DOI
|
15 |
Jang, J.H., J.H. Kim, B.H. Ahn and J.S. Lee. 2011. Physiological functionalities of Vitis hybrid (Sheridan)-Rubus coreanus red wine made by Saccharomyces cerevisiae. Mycobiology 39:109-112.
과학기술학회마을
DOI
|
16 |
Jung, K.A., D. Han, E.K. Kwon, C.H. Lee and Y.E. Kim. 2007. Antifatigue effect of Rubus coreanus Miquel extract in mice. J. Med. Food 10:689-693.
DOI
ScienceOn
|
17 |
Kansra, S., S. Yamagata, L. Sneade, L. Foster and N. Ben Jonathan. 2005. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release. Mol. Cell. Endocrinol. 239:27-36.
DOI
|
18 |
Kelly, P.J. 1996. Is osteoporosis a genetically determined disease? Br. J. Obstet. Gynaecol. 103:20-26.
|
19 |
Kim, S., C.K. Kim, K.S. Lee, J.H. Kim, H. Hwang, D. Jeoung, J. Choe, M.H. Won, H. Lee, K.S. Ha, Y.G. Kwon and Y.M. Kim. 2013. Aqueous extract of unripe Rubus coreanus fruit attenuates atherosclerosis by improving blood lipid profile and inhibiting NF- activation via phase II gene expression. J. Ethnopharmacol. 146:515-524.
DOI
ScienceOn
|
20 |
Karsenty, G. 2003. The complexities of skeletal biology. Nature 423:316-318.
DOI
ScienceOn
|
21 |
Kearns, A.E., S. Khosla and P.J. Kostenuik. 2008. Receptor activator of nuclear factor kappa B ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr. Rev. 29:155-192.
DOI
|
22 |
Choi, C., H. Lee, H. Lim, S. Park, J. Lee and S. Do. 2012. Effect of Rubus coreanus extracts on diabetic osteoporosis by simultaneous regulation of osteoblasts and osteoclasts. Menopause 19:1043-1051.
DOI
|
23 |
Koo, H.J., S.C. Kang and E.H. Sohn. 2013. The optimal combination of the mixture of unripe Rubus coreanus and Astragalus membranaceus in the activation and differentiation of osteoblastic cells. Korean J. Plant Res. 26:658-662 (in Korean).
과학기술학회마을
DOI
|
24 |
Fraser, L.A., K.N. Vogt, J.D. Adachi and L. Thabane. 2011. Fracture risk associated with continuation versus discontinuation of bisphosphonates after 5 years of therapy in patients with primary osteoporosis: a systematic review and meta-analysis. Ther. Clin. Risk Manag. 7:157-166.
|
25 |
Aubin, J.E. and J.T. Triffitt. 2002. Mesenchymal stem cells and osteoblast differentiation: In Bilezikian, J.P., L.G. Raisz and G.A. Rodan (eds.), Principles of Bone Biology, 2nd edn. Academic Press, San Diego, USA. pp. 59-81.
|
26 |
Do, S.H., J.W. Lee, W.I. Jeong, J.Y. Chung, S.J. Park, I.H. Hong, S.K. Jeon, I.S. Lee and K.S. Jeong. 2008. Boneprotecting effect of Rubus coreanus by dual regulation of osteoblasts and osteoclasts. Menopause 15:676-683.
DOI
ScienceOn
|
27 |
Geller, S.E. and F. Kronenberg. 2003. Toward optimal health: the experts discuss the use of botanicals by women. J. Womens Health (Larchmt) 12:847-852.
DOI
|
28 |
Hamdy, N.A. 2007. Targeting the RANK/RANKL/OPG signaling pathway: a novel approach in the management of osteoporosis. Curr. Opin. Investig. Drugs 8:299-303.
|
29 |
Hotokezaka, H., E. Sakai, N. Ohara, Y. Hotokezaka, C. Gonzales, K. Matsuo, Y. Fujimura, N. Yoshida and K. Nakayama. 2007. Molecular analysis of RANKL-independent cell fusion of osteoclast-like cells induced by TNF-alpha, lipopolysaccharide, or peptidoglycan. J. Cell. Biochem. 101:122-134.
DOI
|
30 |
Horwood, N.J., J. Elliott, T.J. Martin and M.T. Gillespie. 1998. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 139:4743-4746.
DOI
|
31 |
Yang, H.M., S.M. Oh, S.S. Lim, H.K. Shin, Y.S. Oh and J.K. Kim. 2008. Antiinflammatory activities of Rubus coreanus depend on the degree of fruit ripening. Phytother. Res. 22:102-107.
DOI
ScienceOn
|
32 |
Thomas, G.P., S.U. Baker, J.A. Eisman and E.M. Gardiner. 2001. Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J. Endocrinol. 170:451-460.
DOI
ScienceOn
|
33 |
Udagawa, N., N. Takahashi, H. Yasuda, A. Mizuno, K. Itoh, Y. Ueno, T. Shinki, M.T. Gillespie, T.J. Martin, K. Higashio and T. Suda. 2000. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141:3478-3484.
DOI
|
34 |
Wensel, T.M., M.M. Iranikhah and T.W. Wilborn. 2011. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women. Pharmacotherapy 31:510-523.
DOI
|